Treats hypertension. ANDA 70923, held by Tp Anda Holdings. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 70923 (Clonidine Hydrochloride), held by Tp Anda Holdings, was first approved by FDA on Sep 4, 1987, with 15 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Clonidine hydrochloride tablets USP are indicated in the treatment of hypertension. Clonidine hydrochloride tablets USP may be employed alone or concomitantly with other antihypertensive agents.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 4, 1987 | Original application | Approved | None posted |
| Clonidine Hydrochloride0.3MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Clonidine Hydrochloride0.2MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Clonidine Hydrochloride0.1MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Clonidine Hydrochloride0.05MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Jan 17, 2013 | Supplement 31Labeling · Standard review | Approved | None posted |
| May 10, 2010 | Supplement 30Labeling | Approved | None posted |
| Mar 11, 2010 | Supplement 29Labeling | Approved | None posted |
| Oct 6, 2005 | Supplement 19Labeling | Approved | None posted |
| Dec 1, 1998 | Supplement 15Manufacturing | Approved | None posted |
| Jun 23, 1997 | Supplement 14Labeling | Approved | None posted |
| Dec 23, 1994 | Supplement 13Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 12Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 11Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 9Manufacturing | Approved | None posted |
| Aug 3, 1989 | Supplement 8Labeling | Approved | None posted |
| Apr 21, 1989 | Supplement 6Manufacturing | Approved | None posted |
| Apr 21, 1989 | Supplement 5Labeling | Approved | None posted |
| Sep 28, 1988 | Supplement 4Labeling | Approved | None posted |
| Jan 20, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Sep 4, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters